↓ Skip to main content

Dove Medical Press

BCL-2 Inhibitor Venetoclax Induces Autophagy-Associated Cell Death, Cell Cycle Arrest, and Apoptosis in Human Breast Cancer Cells

Overview of attention for article published in OncoTargets and therapy, December 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter
2 X users

Readers on

mendeley
36 Mendeley
Title
BCL-2 Inhibitor Venetoclax Induces Autophagy-Associated Cell Death, Cell Cycle Arrest, and Apoptosis in Human Breast Cancer Cells
Published in
OncoTargets and therapy, December 2020
DOI 10.2147/ott.s281519
Pubmed ID
Authors

Ali Alhoshani, Fahad O Alatawi, Fawaz E Al-Anazi, Ibraheem M Attafi, Asad Zeidan, Abdelali Agouni, Heba M El Gamal, Licia S Shamoon, Sarah Khalaf, Hesham M Korashy

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 36 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 11%
Unspecified 3 8%
Researcher 3 8%
Student > Ph. D. Student 3 8%
Student > Doctoral Student 2 6%
Other 6 17%
Unknown 15 42%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 9 25%
Pharmacology, Toxicology and Pharmaceutical Science 4 11%
Unspecified 3 8%
Medicine and Dentistry 2 6%
Agricultural and Biological Sciences 1 3%
Other 1 3%
Unknown 16 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 January 2021.
All research outputs
#16,733,516
of 25,387,668 outputs
Outputs from OncoTargets and therapy
#986
of 3,016 outputs
Outputs of similar age
#307,933
of 518,694 outputs
Outputs of similar age from OncoTargets and therapy
#27
of 93 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 518,694 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 93 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.